The opportunity for biotechs in precision medicine
Within the past 20 years, the field of precision medicine has been transformed. For biotech companies, this new landscape holds tremendous promise for innovation. So, why aren’t more companies leveraging this approach? In this episode, Parexel precision medicine experts Angela Qu and Arlene Hughes join host Alberto Grignolo to discuss this conundrum, and what biotechs should be thinking about right from the start, to open up the opportunity for this approach to help bring innovation and new therapies to more patients.
Related Insights
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
Guide for Real-World Evidence
May 21, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Article
How RWE can help Biotechs optimize the value of their asset
Apr 5, 2021
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Case Study
Case Study Marketing Authorization Transfer
Nov 25, 2021
Related Insights
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
Guide for Real-World Evidence
May 21, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Article
How RWE can help Biotechs optimize the value of their asset
Apr 5, 2021
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Case Study
Case Study Marketing Authorization Transfer
Nov 25, 2021